Press release - 04/05/2026 Recommendation for Better Protection: Outdoor Workers Particularly Vulnerable to Melanoma, Study Finds As the sun rises higher in the sky this spring, UV exposure increases. This should be addressed with proper sun protection. New data shows that people who work outdoors frequently are at a significantly higher risk of developing melanoma on their faces. At the same time, many affected individuals lack awareness of the risks and fail to use systematic sun protection. https://www.gesundheitsindustrie-bw.de/en/article/press-release/recommendation-better-protection-outdoor-workers-particularly-vulnerable-melanoma-study-finds
Press release - 04/05/2026 How personalised is healthcare? This year’s Health Congress at Furtwangen University (HFU) focused on the timely topic of personalised healthcare. With the theme “Health for EVERYONE! – Successful Strategies Through personalised Healthcare,” HFU hosted the event for the 15th time in collaboration with the Black Forest-Baar Health Network, the Furtwangen University Support Association PRO HFU e.V., and the City of Furtwangen.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-personalised-healthcare
Digital bone twin by OSORA medical - 04/05/2026 Fractures in focus: predicting rather than waiting Bone fractures are generally healed by the body without any issues. However, there are hundreds of thousands of cases each year in which a fracture either fails to heal or only does so slowly. To reduce the number of cases where this happens, a start-up called OSORA medical has developed methods to predict the healing process and, if necessary, make preventative adjustments.https://www.gesundheitsindustrie-bw.de/en/article/news/fractures-focus-predicting-rather-waiting
Press release - 30/04/2026 Award for outstanding studies in cancer research Her ground-breaking research studies on the regulation of gene activity have earned Dr Angelika Feldmann the Hella Bühler Prize for 2026, which is endowed with 100,000 euros. https://www.gesundheitsindustrie-bw.de/en/article/press-release/award-outstanding-studies-cancer-research
Press release - 30/04/2026 A single swab is sufficient: Study paves the way for simplified tuberculosis diagnosis Led by researchers from Heidelberg Faculty of Medicine at Heidelberg University and the University of California, San Francisco (USA), an international research team has evaluated a novel approach for the diagnosis of pulmonary tuberculosis. The method enables detection of Mycobacterium tuberculosis without laboratory infrastructure, within a markedly shorter time frame than conventional diagnostics, and using a simple swab. https://www.gesundheitsindustrie-bw.de/en/article/press-release/single-swab-sufficient-study-paves-way-simplified-tuberculosis-diagnosis
Press release - 30/04/2026 The white spot of inner ear research A new technique based on labelled sugar molecules is providing previously unknown insights into the inner ear. A study by the University of Konstanz and Charité-Universitätsmedizin Berlin shows that the cupula in the inner ear of zebrafish completely regenerates within approximately two months. These findings open up a new avenue for research into sudden hearing loss and acute disorders of the sense of balance.https://www.gesundheitsindustrie-bw.de/en/article/press-release/white-spot-inner-ear-research
Press release - 30/04/2026 More collaboration, more impact: The Innovation Alliance Foundation Freiburg adopts a new resolution The University of Freiburg works closely with partners from various sectors including academia, business, politics and public administration through the Innovation Alliance Foundation Freiburg. The resolution that has been adopted reinforces the shared goal of establishing Freiburg as an attractive innovation hub with international appeal.https://www.gesundheitsindustrie-bw.de/en/article/press-release/more-collaboration-more-impact-innovation-alliance-foundation-freiburg-adopts-new-resolution
Press release - 28/04/2026 Breast cancer brain metastases: patterns in immune cells could improve therapy decisions Brain metastases are among the most serious complications of breast cancer. Researchers at Heidelberg University, DKFZ, and UKHD have concluded an investigation of the immune cells in the brain tissue surrounding these breast cancer brain metastases. Their findings: spatial distribution patterns of immune cells are associated with prolonged patient survival. These findings could help to guide use of immunotherapies for breast cancer patients.https://www.gesundheitsindustrie-bw.de/en/article/press-release/breast-cancer-brain-metastases-patterns-immune-cells-could-improve-therapy-decisions
Press release - 27/04/2026 Heidelberg and Mainz agree on joint innovation partnership - Strengthening the Neckar-Rhine-Main biotech region The cities of Heidelberg and Mainz want to work closely together in the future: Their aim is to further develop the Neckar-Rhine-Main region as an international innovation and biotech region. To this end, Heidelberg Mayor Würzner and Mainz Mayor Haase signed a MoU at Heidelberg City Hall on Friday, April 24, 2026. Those responsible for the central innovation and development structures of both cities also took part in the signing.https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-and-mainz-agree-joint-innovation-partnership-strengthening-neckar-rhine-main-biotech-region
Press release - 24/04/2026 New Medical Director of the Department of Nephrology Prof. Dr. Halbritter has served as the new Medical Director of the Department of Nephrology at the Medical Center – University of Freiburg since April 2026. With his expertise, he is enhancing care for patients with kidney disease: The goal is to prevent kidney failure through early diagnosis and the implementation of strategies to slow disease progression. For cases where kidney failure has already occurred, the focus is on organ replacement.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-medical-director-department-nephrology
Event - 02/12/2026 - 04/12/2026 2026 Max Planck Freiburg Epigenetics Meeting Freiburg, Germany , Registration deadline: 07/09/2026, Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/2026-max-planck-freiburg-epigenetics-meeting
Press release - 23/04/2026 Molecular research: When speed meets precision Within biological cells, molecules are constantly in motion. Investigating these motions, however, is still difficult, due to the fact that these processes occur on very small length and time scales. To overcome these challenges, researchers from HITS and MPI-P have developed a simulation method that works rapidly and can predict chemical processes in cells with high precision. Their findings have been published in Nature Communications.https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-research-when-speed-meets-precision
Press release - 22/04/2026 Higher Biological Age - Higher Cancer Risk Not only actual chronological age, but also individual aging at the molecular level is a key factor in the development of cancer. This was discovered by scientists at the DKFZ and the Saarland Cancer Registry. If the so-called “epigenetic clocks” indicate accelerated biological aging, the likelihood of a cancer diagnosis increases. This finding could help identify at-risk groups and make early detection screenings more targetedhttps://www.gesundheitsindustrie-bw.de/en/article/press-release/higher-biological-age-higher-cancer-risk
Press release - 22/04/2026 Turning four into two: How duplicated genomes become diploid again Genome duplication probably gave biodiversity a decisive evolutionary boost. A Chinese-German research team led by Axel Meyer from the University of Konstanz has now investigated the early phases of the process known as re-diploidization. The results show that the fusion of chromosome sets is asynchronous.https://www.gesundheitsindustrie-bw.de/en/article/press-release/turning-four-two-how-duplicated-genomes-become-diploid-again
Press release - 20/04/2026 3D-Printed Tissue Substitute A novel biomimetic tissue substitute combines precisely tunable mechanical properties with biological functionality and is now ready for applications in medical technology. The material was developed in the »PolyKARD« project by Fraunhofer IAP and the NMI Natural and Medical Sciences Institute. From 20.-24.04, 2026, the material will be presented together with further developments at the Hannover Messe, Fraunhofer joint booth.https://www.gesundheitsindustrie-bw.de/en/article/press-release/3d-printed-tissue-substitute
Press release - 15/04/2026 Why do women’s brains age differently? Estrogen does more than regulate reproduction — it helps brain cells handle stress. When levels decline after menopause, this ability is reduced, and these hormonal changes are believed to contribute to the increased risk of Alzheimer’s disease in women. MPI-IE researcher María José Pérez Jiménez has received the Klaus Tschira Boost Fund to investigate why — and whether these cellular responses can be restored.https://www.gesundheitsindustrie-bw.de/en/article/press-release/why-do-womens-brains-age-differently
Press release - 15/04/2026 Electricity without cables or plugs How can you charge electric cars without plugging them into the power grid for hours on end? How can industrial robots be “refueled” during operation? And how does wireless energy transfer improve medical technology? These questions have occupied Prof. Nejila Parspour, Director of the Institute of Electrical Energy Conversion (IEW) at the University of Stuttgart, for more than twenty years.https://www.gesundheitsindustrie-bw.de/en/article/press-release/electricity-without-cables-or-plugs
Press release - 15/04/2026 Pacemakers for the Brain Brain-computer interfaces can read neural signals and influence brain activity. We spoke with Pascal Fries about how this technology can benefit people with neurological and psychiatric conditions, future developments, and his views on ethical boundaries.https://www.gesundheitsindustrie-bw.de/en/article/press-release/pacemakers-brain
Press release - 14/04/2026 T-helper cells switch to self-protection mode under prolonged stress Chronic infections cause long-term changes in key immune cells. T helper cells suppress their immune function to ensure their survival. New targets for vaccines and cancer immunotherapies.https://www.gesundheitsindustrie-bw.de/en/article/press-release/t-helper-cells-switch-self-protection-mode-under-prolonged-stress-1
Press release - 10/04/2026 Lancet Countdown Europe: New Report on Health and Climate Change Europe’s dependence on fossil fuels is not only making the continent economically and politically vulnerable, it also has consequences for the population’s health. Growing air pollution, heat damage and the climate-related spread of infectious diseases are looming, warns the 2026 Europe Report of the Lancet Countdown on Health and Climate Change, which its co-directors are about to present to the public. https://www.gesundheitsindustrie-bw.de/en/article/press-release/lancet-countdown-europe-new-report-health-and-climate-change
Press release - 10/04/2026 New study identifies clinically relevant changes in airway wall thickness in COPD and at-risk individuals A recent study published in the European Respiratory Journal provides important new insights into the early identification and monitoring of chronic obstructive pulmonary disease (COPD). The focus is on airway wall thickness as an imaging marker for structural remodeling processes in the lungs.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-study-identifies-clinically-relevant-changes-airway-wall-thickness-copd-and-risk-individuals
Press release - 10/04/2026 Vitamin B12 Found to Drive Inherited Behavioural Changes Across Generations A team of researchers from the Department of Integrative Evolutionary Biology at the Max Planck Institute for Biology Tübingen has discovered that vitamin B12 plays a key role in transmitting behavioural memories across generations. The study shows for the first time how a nutrient from the diet can, without altering the genome, influence behaviour over multiple generations.https://www.gesundheitsindustrie-bw.de/en/article/press-release/vitamin-b12-found-drive-inherited-behavioural-changes-across-generations
Press release - 10/04/2026 Molecular analyses could improve treatment options for a rare soft tissue tumor Desmoplastic small- and round-cell tumor is rare, aggressive, and difficult to treat. Researchers at the National Center for Tumor Diseases (NCT) Heidelberg and the German Cancer Research Center (DKFZ) have comprehensively analyzed 30 tumors and identified potential personalized treatment options for nearly all patients. In some patients, new targeted approaches were able to halt the disease for a surprisingly long time.https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-analyses-could-improve-treatment-options-rare-soft-tissue-tumor
Press release - 09/04/2026 When oxygen determines if a limb can regrow Can Aztekin and his team have discovered how oxygen-sensing explains why amphibians regenerate limbs and mammals do not.https://www.gesundheitsindustrie-bw.de/en/article/press-release/when-oxygen-determines-if-limb-can-regrow
Photoimmunotherapy - 09/04/2026 Switching off tumours with light: how photons can be used to target prostate cancer Prostate cancer is the most common cancer among men in Germany. Relapses and the harsh side effects of traditional treatments remain a major challenge, even with advanced surgical techniques. At the University of Freiburg, Dr. Wolf is pioneering the development of photoimmunotherapy. Photoimmunotherapy combines light, antibodies and a specialised dye to precisely target tumour cells - simultaneously 'waking up' the immune system.https://www.gesundheitsindustrie-bw.de/en/article/news/switching-tumours-light-how-photons-can-be-used-target-prostate-cancer